Literature DB >> 32223003

European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitis.

A Wollenberg1,2, C Flohr3, D Simon4, M J Cork5, J P Thyssen6,7, T Bieber8, M S de Bruin-Weller9, S Weidinger10, M Deleuran11, A Taieb12, C Paul13, M Trzeciak14, T Werfel15, J Seneschal16, S Barbarot17, U Darsow18, A Torrelo19, J-F Stalder20, Å Svensson21, D Hijnen22, C Gelmetti23, Z Szalai24, U Gieler25, L De Raeve26, B Kunz27, P Spuls28, L B von Kobyletzki29,30, R Fölster-Holst10, P V Chernyshov31, S Christen-Zaech32, A Heratizadeh15, J Ring33,34, C Vestergaard11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32223003     DOI： 10.1111/jdv.16411

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  44 in total

1.  Impact of COVID-19 on patients with atopic dermatitis.

Authors:  Teresa Grieco; Camilla Chello; Alvise Sernicola; Rovena Muharremi; Simone Michelini; Giovanni Paolino; Giorgia Carnicelli; Paolo Daniele Pigatto
Journal:  Clin Dermatol       Date:  2021-07-17       Impact factor: 3.541

2.  SARS-CoV-2 infection in patients with atopic dermatitis: a cross-sectional study.

Authors:  C Nguyen; K Yale; F Casale; A Ghigi; K Zheng; J I Silverberg; N A Mesinkovska
Journal:  Br J Dermatol       Date:  2021-06-02       Impact factor: 11.113

Review 3.  A compendium answering 150 questions on COVID-19 and SARS-CoV-2.

Authors:  Carmen Riggioni; Pasquale Comberiati; Mattia Giovannini; Ioana Agache; Mübeccel Akdis; Magna Alves-Correia; Josep M Antó; Alessandra Arcolaci; Ahmet Kursat Azkur; Dilek Azkur; Burcin Beken; Cristina Boccabella; Jean Bousquet; Heimo Breiteneder; Daniela Carvalho; Leticia De Las Vecillas; Zuzana Diamant; Ibon Eguiluz-Gracia; Thomas Eiwegger; Stefanie Eyerich; Wytske Fokkens; Ya-Dong Gao; Farah Hannachi; Sebastian L Johnston; Marek Jutel; Aspasia Karavelia; Ludger Klimek; Beatriz Moya; Kari C Nadeau; Robyn O'Hehir; Liam O'Mahony; Oliver Pfaar; Marek Sanak; Jürgen Schwarze; Milena Sokolowska; María J Torres; Willem van de Veen; Menno C van Zelm; De Yun Wang; Luo Zhang; Rodrigo Jiménez-Saiz; Cezmi A Akdis
Journal:  Allergy       Date:  2020-07-20       Impact factor: 14.710

4.  Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports.

Authors:  S Ferrucci; M Romagnuolo; L Angileri; E Berti; S Tavecchio
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-08       Impact factor: 9.228

5.  Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID-19 pandemic.

Authors:  P V Chernyshov; L Tomas-Aragones; M Augustin; A Svensson; A Bewley; F Poot; J C Szepietowski; S E Marron; L Manolache; N Pustisek; A Suru; C M Salavastru; C Blome; M S Salek; D Abeni; F Sampogna; F Dalgard; D Linder; A W M Evers; A Y Finlay
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-29       Impact factor: 9.228

6.  Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement.

Authors:  Alessandra Vultaggio; Ioana Agache; Cezmi A Akdis; Mubeccel Akdis; Sevim Bavbek; Apostolos Bossios; Jean Bousquet; Onur Boyman; Adam M Chaker; Susan Chan; Alexia Chatzipetrou; Wojciech Feleszko; Davide Firinu; Marek Jutel; Paula Kauppi; Ludger Klimek; Antonios Kolios; Akash Kothari; Marek L Kowalski; Andrea Matucci; Oscar Palomares; Oliver Pfaar; Barbara Rogala; Eva Untersmayr; Thomas Eiwegger
Journal:  Allergy       Date:  2020-11       Impact factor: 14.710

7.  Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.

Authors:  Urszula Radzikowska; Mei Ding; Ge Tan; Damir Zhakparov; Yaqi Peng; Paulina Wawrzyniak; Ming Wang; Shuo Li; Hideaki Morita; Can Altunbulakli; Matthias Reiger; Avidan U Neumann; Nonhlanhla Lunjani; Claudia Traidl-Hoffmann; Kari C Nadeau; Liam O'Mahony; Cezmi Akdis; Milena Sokolowska
Journal:  Allergy       Date:  2020-08-24       Impact factor: 14.710

Review 8.  Challenges of COVID-19 pandemic for dermatology.

Authors:  Uwe Wollina
Journal:  Dermatol Ther       Date:  2020-04-30       Impact factor: 3.858

9.  SARS-CoV-2 asymptomatic infection in a patient under treatment with dupilumab.

Authors:  F Caroppo; G Biolo; A Belloni Fortina
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-06-08       Impact factor: 9.228

10.  Association of COVID-19 with skin diseases and relevant biologics: a cross-sectional study using nationwide claim data in South Korea.

Authors:  S I Cho; Y E Kim; S J Jo
Journal:  Br J Dermatol       Date:  2020-10-13       Impact factor: 11.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.